Synthetic biology will be one of the driving technological forces of this century. By transforming the complexity and diversity of life into a technology malleable by man, it simultaneously offers some of science’s highest hopes and gravest threats. Like splitting the atom, synthetic biology holds a great wealth of power that must be wielded with care.
Bioengineer Drew Endy is the leading enabler of open-source biotechnology. Technology historian Jim Thomas is the leading critic of biotech, based with ETC Group in Ottawa. Moderated by Stewart Brand, they will meet to discuss how the emerging and potentially revolutionary capabilities of synthetic biology can be utilized safely, equitably and openly.
Synthetic biology is swarming ahead all over the world, at a self-accelerating pace far greater than Moore’s Law, with a range of impacts far greater than genetically engineered food crops. Jim Thomas raises the question: "Is Synthetic Biology reckless or wise from the perspective of ‘the long now?’. I feel the synthetic biology community is driven by immensely short term assumptions and motivations, and as a result the medium term prospect for this platform holds both predictable problems and nasty surprises."